Marina Díaz‐Beyá

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Marta Pratcorona, Salut Brunet, Josep Nomdedéu et al. · Blood · 2013 · 279 citations

The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last Decade

Enric Carreras, Marina Díaz‐Beyá, Laura Rosiñol et al. · Biology of Blood and Marrow Transplantation · 2011 · 201 citations · Full text

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

Valentín Ortiz‐Maldonado, Susana Rives, María Castellà et al. · Molecular Therapy · 2020 · 151 citations · Full text

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients

Alejandra Martínez‐Trillos, Anna Gayà, Margherita Maffioli et al. · Annals of Hematology · 2010 · 146 citations · Full text

The lincRNA<i>HOTAIRM1</i>, located in the<i>HOXA</i>genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

Marina Díaz‐Beyá · Oncotarget · 2015 · 130 citations · Full text